Cargando…
DNA bar coding and pyrosequencing to analyze adverse events in therapeutic gene transfer
Gene transfer has been used to correct inherited immunodeficiencies, but in several patients integration of therapeutic retroviral vectors activated proto-oncogenes and caused leukemia. Here, we describe improved methods for characterizing integration site populations from gene transfer studies usin...
Autores principales: | Wang, Gary P., Garrigue, Alexandrine, Ciuffi, Angela, Ronen, Keshet, Leipzig, Jeremy, Berry, Charles, Lagresle-Peyrou, Chantal, Benjelloun, Fatine, Hacein-Bey-Abina, Salima, Fischer, Alain, Cavazzana-Calvo, Marina, Bushman, Frederic D. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2396413/ https://www.ncbi.nlm.nih.gov/pubmed/18411205 http://dx.doi.org/10.1093/nar/gkn125 |
Ejemplares similares
-
DNA bar coding and pyrosequencing to identify rare HIV drug resistance mutations
por: Hoffmann, Christian, et al.
Publicado: (2007) -
A method to sequence and quantify DNA integration for monitoring outcome in gene therapy
por: Brady, Troy, et al.
Publicado: (2011) -
Biosafety Studies of a Clinically Applicable Lentiviral Vector for the Gene Therapy of Artemis-SCID
por: Charrier, Sabine, et al.
Publicado: (2019) -
Real-Time Definition of Non-Randomness in the Distribution of Genomic Events
por: Abel, Ulrich, et al.
Publicado: (2007) -
Gene therapy for severe combined immunodeficiencies and beyond
por: Fischer, Alain, et al.
Publicado: (2019)